Atlas Trials

Metolazone As Early Add On Therapy For Acute Decompensated Heart Failure (MELT-HF)--A Single Center Pilot Study.

Clinical trial NCT02620384 · TERMINATED

Trial details

NCT number
NCT02620384
Sponsor
Aultman Health Foundation
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Acute Decompensated Heart Failure
Start date
2015-10-01
Primary completion
2017-11-29
Enrollment
147

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.